Experimental Papers
Copyright ©The Author(s) 1996. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 15, 1996; 2(3): 134-135
Published online Sep 15, 1996. doi: 10.3748/wjg.v2.i3.134
Prevention of liver metastasis by intraperitoneal 5-FU chemotherapy in nude mice inoculated with human colon cancer cells
Guo-Guang Feng, Xi-Geng Zhou, Bao-Ming Yu
Guo-Guang Feng, Xi-Geng Zhou, Bao-Ming Yu, Department of Surgery, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China
Guo-Guang Feng, Associate Professor of Surgery has published seven papers.
Author contributions: All authors contributed equally to the work.
Supported by the National Science Foundation of China, No.39270650
Correspondence to: Dr. Guo-Guang Feng, Associate Professor, Department of Surgery, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China
Telephone: +86-21-64370045-6151
Received: July 29, 1996
Revised: August 9, 1996
Accepted: August 23, 1996
Published online: September 15, 1996
Abstract

AIM: To prevent hepatic metastasis by regional adjuvant chemotherapy after radical surgery for colon cancer.

METHODS: A nude mouse model of human colon cancer (HCC) was used to evaluate the prevention of metastasis of HCC cells following the application of early postoperative intraperitoneal (IP) high-dose 5-fluorouracil chemotherapy.

RESULTS: The incidence of liver metastasis was decreased by 40%, and the mean number of metastatic liver nodules was reduced by 50.89%. Compared with controls, 5-FU 40 mg in NS 40 mL/kg IP for 2 consecutive days prolonged mean survival by 48.21%.

CONCLUSION: IP is a promising and effective novel regional adjuvant chemotherapy for the prevention of liver metastasis of HCC cells after radical surgery for colon cancer.

Keywords: Colonic neoplasms/surgery, Liver neoplasms/drug therapy, Fluorouracil/therapeutic use, Liver neoplasms/secondary